HEALTH PROFESSIONAL · SOURCE READING

Biological therapies

Source: Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: October 25, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Recurrent Thymoma and Thymic Carcinoma / Treatment Options for Recurrent Thymoma and Thymic Carcinoma

Octreotide with or without prednisone may induce responses in patients with octreotide scan–positive thymoma. Objective responses have also been observed with sunitinib and everolimus in patients with recurrent TETs.

Continue within this section

Octreotide with or without prednisone →Sunitinib →Everolimus →Lenvatinib →

Preserved source evidence · Not medical advice